Access cutting-edge opioid use disorder treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access opioid use disorder specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid use disorder treatment provided free
This study will evaluate the effectiveness of a new pharmacological approach to increase efficacy of treatment with extended release naltrexone (XR-naltrexone) for individuals with opioid use disorder by combining it with buprenorphine-naloxone. This is a two arm, double-blind, placebo-controlled study to examine whether addition of buprenorphine-naloxone will improve treatment retention, reduce opioid craving, and improve mood over 24 weeks of treatment with extended release naltrexone (XR-nalt
Sponsor: New York State Psychiatric Institute
Check if you qualify for this opioid use disorder clinical trial in New York, NY
If you're searching for opioid use disorder treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.